Results 21 to 30 of about 580,319 (279)

Uterine Neoplasms Composed of Rhabdoid Cells Do Not Exhibit Loss of INI1 Immunoreactivity and Are Not Related to Childhood Malignant Rhabdoid Tumor

International Journal of Gynecological Pathology, 2008
Maysa Al‐Hussaini, Lynn Hirschowitz, W. Glenn McCluggage   +2 more
openalex   +2 more sources

Educational Case: A Uterine Neoplasm [PDF]

Academic Pathology, 2018
The following fictional case is intended as a learning tool within the Pathology Competencies for Medical Education (PCME), a set of national standards for teaching pathology. These are divided into three basic competencies: Disease Mechanisms and Processes, Organ System Pathology, and Diagnostic Medicine and Therapeutic Pathology.
openaire   +4 more sources

European guidelines from the EHTG and ESCP for Lynch syndrome: an updated third edition of the Mallorca guidelines based on gene and gender

BJS (British Journal of Surgery), EarlyView., 2020
Recommendations for clinical and molecular identification of LS, surgical and endoscopic management of LS‐associated colorectal cancer and preventive measures for cancer were produced. The emphasis was on surgical and gastroenterological aspects of the cancer spectrum.
T. T. Seppälä, A. Latchford, I. Negoi, A. Sampaio Soares, R. Jimenez‐Rodriguez, L. Sánchez‐Guillén, D. G. Evans, N. Ryan, E. J. Crosbie, M. Dominguez‐Valentin, J. Burn, M. Kloor, M. von Knebel Doeberitz, F. J. B. van Duijnhoven, P. Quirke, J. R. Sampson, P. Møller, G. Möslein, on behalf of the European Hereditary Tumour Group (EHTG) and European Society of Coloproctology (ESCP)   +18 more
wiley   +1 more source

PEComa-A Rare Uterine Neoplasm: A Case Report

Journal of Reproduction & Infertility, 2022
Background: Perivascular Epithelioid Cell Tumors (PEComas) are rare mesen-chymal tumors originating from perivascular epithelioid cells. The second common affected organ is uterine. Most of PEComas are benign and patients have good prognosis. At the present time, surgery is the main treatment and adjuvant chemo-therapy is used in malignant cases ...
Padmehr, Roya, Arasteh, Saeid, Aminimoghaddam, Soheila, Rahbari, Ali, Bohloli, Mehrdad, Mir Eskandari, Seyed Mohammad, Mohabbat Dar, Hamid, Ahmad Beigi, Morvarid, Talebi Biderouni, Negin   +8 more
openaire   +1 more source

[New features in the 2014 WHO classification of uterine neoplasms].

Der Pathologe, 2016
The 2014 World Health Organization (WHO) classification of uterine tumors revealed simplification of the classification by fusion of several entities and the introduction of novel entities.
S. Lax
semanticscholar   +1 more source

Uterine Lipoleiomyoma: a rare variant of benign uterine neoplasm

International Journal of Reproduction, Contraception, Obstetrics and Gynecology, 2019
The lipomatous tumors are very rare benign neoplasms of the uterus. Lipoleiomyoma is a benign tumor which is variant of leiomyoma. It has similar clinical course and presentation like uterine leiomyoma and is typically found in postmenopausal women. Authors report a case of 45 years female presented with a complaint of increased frequency of menstrual ...
Abhijit Phalke, Nitin Kshirsagar, Shubham S. Jagtap, Sunil V Jagtap, Nitesh Nasre   +4 more
openaire   +3 more sources

CREB fusion–associated epithelioid mesenchymal neoplasms of the female adnexa: three cases documenting a novel location of an emerging entity and further highlighting an ambiguous misleading immunophenotype

Virchows Archiv, 2023
EWSR1/FUS-CREB -rearranged mesenchymal neoplasms are an emerging heterogeneous group of soft tissue tumors that encompasses low-grade lesions (angiomatoid fibrous histiocytoma/AFH) and a group of predominantly intra-abdominal aggressive sarcomas with ...
A. Trécourt, N. Macagno, C. Ngo, C. Philip, Jonathan Lopez, J. Ferreira, C. Alves-Vale, I. Ray-Coquard, C. Genestie, A. Agaimy, M. Devouassoux-Shisheboran   +10 more
semanticscholar   +1 more source

ShcD adaptor protein drives invasion of triple negative breast cancer cells by aberrant activation of EGFR signaling

Molecular Oncology, EarlyView.
We identified adaptor protein ShcD as upregulated in triple‐negative breast cancer and found its expression to be correlated with reduced patient survival and increased invasion in cell models. Using a proteomic screen, we identified novel ShcD binding partners involved in EGFR signaling pathways.
Hayley R. Lau, Hayley S. Smith, Begüm Alural, Claire E. Martin, Laura A. New, Manali Tilak, Sara L. Banerjee, Hannah N. Robeson, Nicolas Bisson, Anne‐Claude Gingras, Jasmin Lalonde, Nina Jones   +11 more
wiley   +1 more source

Comprehensive Review of Uterine Fibroids: Developmental Origin, Pathogenesis, and Treatment

Endocrine reviews, 2021
Uterine fibroids are benign monoclonal neoplasms of the myometrium, representing the most common tumors in women worldwide. To date, no long-term or noninvasive treatment option exists for hormone-dependent uterine fibroids, due to the limited knowledge ...
Qiwei Yang, M. Ciebiera, M. V. Bariani, Mohamed Ali, Hoda Elkafas, T. Boyer, A. Al-Hendy   +6 more
semanticscholar   +1 more source

Inhibitor of DNA binding‐1 is a key regulator of cancer cell vasculogenic mimicry

Molecular Oncology, EarlyView.
Elevated expression of transcriptional regulator inhibitor of DNA binding 1 (ID1) promoted cancer cell‐mediated vasculogenic mimicry (VM) through regulation of pro‐angiogenic and pro‐cancerous genes (e.g. VE‐cadherin (CDH5), TIE2, MMP9, DKK1). Higher ID1 expression also increased metastases to the lung and the liver.
Emma J. Thompson, Emma L. Dorward, Kristyn Jurrius, Nathalie Nataren, Markus Tondl, Kay K. Myo Min, Michaelia P. Cockshell, Anahita Fouladzadeh, John Toubia, Mark DeNichilo, Delphine Merino, Claudine S. Bonder   +11 more
wiley   +1 more source